Supporting this, the SUSTAIN-6 cardiovascular outcomes trial found that once-weekly semaglutide drugs carry a higher risk of diabetic retinopathy progression
However, no human pharmacokinetic data exists to validate this
Millions of people are taking weight loss medications across the UK, but this evidence shows the risks of ignoring strength training and exercise during treatment, says Dr Matthew Wade, Interim Director of Research at ukactive
This treatment focuses on providing benefits such as increased energy levels, improved physical recovery, heightened immune support, and enhanced emotional balance
The doses used (0.1 mg/kg daily) are research doses in mice
Food and Drug Administration (FDA) and Therapeutic Goods Administration (TGA), have raised concerns about Melanotan 2 due to reported adverse effects and limited long-term safety data